Inventiva S.A Rings The Nasdaq Stock Market Closing Bell

Published

Inventiva S.A (Nasdaq: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases rings the Nasdaq Closing Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now